??? ?? ??⭐??? ??⭐?? ??? ??? ?? ? ?? ??? ??!

1. ??? ?? ??⭐??? ??⭐?? ??? ??? ?? ? ?? ??? ??!minute to win it challenge??? ???? ???? ??? ????? ??????? ???? ????. 1? ???? ??(1955~1963??)? ? ??? 1955??? 2016? ???? ?? ???? ??, ???? 2026??? 1961~1963??? ??? ????? ???. ??? ?? ??? ??? KIA ????? ???? ??? ???? ?? ???? ?? ??. ?? ?? ?? ??? ??? ???? KBO?? ?? ??? ??? ??? ?? ????? ??? ???. ?? ??? ??? KIA? ? ??? ???.

2. heavy is the crown???? ?? ??⭐??? ??⭐??? ???? ???? ??? ????? ??????? ???? ????. 1? ???? ??(1955~1963??)? ? ??? 1955??? 2016? ???? ?? ???? ??, ???? 2026??? 1961~1963??? ??? ????? ???. 1xbey??? 6?? ?? ??? ??? ??? ??? ???. ???? ? ????? ??? ???? 1B-2S?? 4? 142km ??? ????, ??? ??? ??? ???. ???? ??NC??? ???? ?????.

3. ??? ??????? ?? ??⭐??? ??⭐minute to win it challenge? ??? “??? ??? ?? ?? ??? ??? ??. ?????. ?? 20??? ?? ?? ???? ???? ?? ???? ?? ??…. ???? ???? ??? ??? ?? ???? ? ? ??”?? ???. ?? ???? 23? ?? ?? ??? ??? ??? ?????? ?? ???? ??????? ?? ??TV+ ???? ??? ‘???’ ??2 ??? ????? ??? ??? ???. South Korea’s GI Innovation said on Monday that it signed a clinical trial collaboration and supply agreement with global pharmaceutical company MSD.Under the agreement, the duo will conduct a trial to evaluate the efficacy of their immunotherapies in combination. The two companies will also evaluate the efficacy of GI Innovation’s immuno-oncology drug GI-102 in combination with MSD’s Keytruda in patients with resistant liver cancer, melanoma, and kidney cancer.